Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,676 public trials 321 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

NCT06892522

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 273132 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 273129 Denver, Colorado, United States
  • Moffitt Cancer Center /ID# 272628 Tampa, Florida, United States
View all 34 locations
View Trial Details
Recruiting

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

NCT05469893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06121843

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 19 locations
View Trial Details
Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

NCT02343042

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Jonnsson Comprehensive Cancer Center / University of Los Angeles Los Angeles, California, United States
  • Sarah Cannon-Colorado Blood Cancer Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT05650632

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona /ID# 251405 Phoenix, Arizona, United States
  • Highlands Oncology Group - Springdale /ID# 267742 Springdale, Arkansas, United States
  • Rocky Mountain Cancer Centers - Aurora /ID# 268574 Aurora, Colorado, United States
  • Medical Oncology Hematology Consultants /ID# 268560 Newark, Delaware, United States
View all 46 locations
View Trial Details

Related conditions